Cargando…

LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis

OBJECTIVE: Long non-coding RNA (lncRNA) ANRIL is emerging as a crucial role in ovarian cancer progression and prognosis. However, the precise molecular mechanism of ANRIL on ovarian cancer is not known. Thus, we aim to study the underlying mechanism of ANRIL on the action. METHODS: The MTT assay ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ke, Hu, Yu-Bo, Zhao, Ye, Ye, Cong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826075/ https://www.ncbi.nlm.nih.gov/pubmed/33500630 http://dx.doi.org/10.2147/OTT.S273614

Ejemplares similares

LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis [Retraction]
Publicado: (2021)

lncRNA FOXD2-AS1 promotes hemangioma progression through the miR-324-3p/PDRG1 pathway
por: Zhao, Tiancheng, et al.
Publicado: (2020)

LncRNA ANRIL/miR‐125a axis exhibits potential as a biomarker for disease exacerbation, severity, and inflammation in bronchial asthma
por: Ye, Shenglan, et al.
Publicado: (2019)

LncRNA ANRIL/miR-7-5p/TCF4 axis contributes to the progression of T cell acute lymphoblastic leukemia
por: Li, Gang, et al.
Publicado: (2020)

Expression profile of LncRNA ANRIL, miR-186, miR-181a, and MTMR-3 in patients with preeclampsia
por: Ayoub, Shymaa E., et al.
Publicado: (2023)

LncRNA ANRIL-mediated miR-181b-5p/S1PR1 axis is involved in the progression of uremic cardiomyopathy through activating T cells
por: Xu, Ying, et al.
Publicado: (2022)

Upregulating the Expression of LncRNA ANRIL Promotes Osteogenesis via the miR-7-5p/IGF-1R Axis in the Inflamed Periodontal Ligament Stem Cells
por: Bian, Minxia, et al.
Publicado: (2021)

lncRNA NR_038323 Suppresses Renal Fibrosis in Diabetic Nephropathy by Targeting the miR-324-3p/DUSP1 Axis
por: Ge, Yanni, et al.
Publicado: (2019)

LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis
por: Miao, Jin-Tian, et al.
Publicado: (2019)

Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
por: Zheng, Miao, et al.
Publicado: (2020)

Mechanism of lncRNA-ANRIL/miR-181b in autophagy of cardiomyocytes in mice with uremia by targeting ATG5
por: Xu, Ying, et al.
Publicado: (2021)

The lncRNA ANRIL is down-regulated in peripheral blood of patients with periodontitis
por: Gholami, Leila, et al.
Publicado: (2020)

lncRNA SNHG1 Promotes Progression of Cervical Cancer Through miR-195/NEK2 Axis
por: Ji, Yuan Yuan, et al.
Publicado: (2020)

LncRNA GAS5 suppresses ovarian cancer progression by targeting the miR-96-5p/PTEN axis
por: Dong, Qian, et al.
Publicado: (2021)

Downregulation of lncRNA ANRIL suppresses growth and metastasis in human osteosarcoma cells
por: Guan, Hongya, et al.
Publicado: (2018)

Circulating expression and clinical significance of LncRNA ANRIL in diabetic kidney disease
por: Zhu, Yanting, et al.
Publicado: (2022)

LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/miR-324-3p-SIRT5 axis in lung adenocarcinoma
por: Wu, Jie, et al.
Publicado: (2021)

Effects of lncRNA LINC01320 on Proliferation and Migration of Pancreatic Cancer Cells through Targeted Regulation of miR-324-3p
por: Meng, Hua, et al.
Publicado: (2021)

Correction to: LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/ miR-324-3p-SIRT5 axis in lung adenocarcinoma
por: Wu, Jie, et al.
Publicado: (2021)

Correction: LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/ miR-324-3p-SIRT5 axis in lung adenocarcinoma
por: Wu, Jie, et al.
Publicado: (2023)

LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-128-3p/CKD14 axis
por: Zhu, Lijuan, et al.
Publicado: (2020)

LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
por: Liang, Yiran, et al.
Publicado: (2020)

LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214
por: Chen, Ying, et al.
Publicado: (2018)

Knockdown of lncRNA ANRIL suppresses the production of inflammatory cytokines and mucin 5AC in nasal epithelial cells via the miR-15a-5p/JAK2 axis
por: Liu, Huo-Wang, et al.
Publicado: (2021)

LncRNA ANRIL promotes HR repair through regulating PARP1 expression by sponging miR-7-5p in lung cancer
por: Du, Zhipeng, et al.
Publicado: (2023)

LncRNA MALAT1 Promotes Survival of Epithelial Ovarian Cancer Cells by Downregulating miR-145-5p
por: Wang, Ke, et al.
Publicado: (2020)

Reciprocal Regulation between lncRNA ANRIL and p15 in Steroid-Induced Glaucoma
por: Wan, Peixing, et al.
Publicado: (2022)

Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA-Meg3/miR-421/PDGFRA axis
por: Ye, Weiping, et al.
Publicado: (2019)

LncRNA PCAT-1 upregulates RAP1A through modulating miR-324-5p and promotes survival in lung cancer
por: Huang, Na, et al.
Publicado: (2019)

LncRNA LINC00963 Promotes Tumorigenesis and Radioresistance in Breast Cancer by Sponging miR-324-3p and Inducing ACK1 Expression
por: Zhang, Na, et al.
Publicado: (2019)

LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR‐9‐5p/QKI‐5 axis
por: Wu, Meng, et al.
Publicado: (2018)

lncRNA LUNAR1 accelerates colorectal cancer progression by targeting the miR-495-3p/MYCBP axis
por: Qian, Jiajie, et al.
Publicado: (2020)

LncRNA MALAT1/miR‐129 axis promotes glioma tumorigenesis by targeting SOX2
por: Xiong, Zhiyong, et al.
Publicado: (2018)

LncRNA LINC01303 Promotes the Progression of Oral Squamous Cell Carcinomas via the miR-429/ZEB1/EMT Axis
por: Sun, Bo, et al.
Publicado: (2021)

The interplay of LncRNA ANRIL and miR‐181b on the inflammation‐relevant coronary artery disease through mediating NF‐κB signalling pathway
por: Guo, Feng, et al.
Publicado: (2018)

lncRNA ANRIL aggravates the chemoresistance of pancreatic cancer cells to gemcitabine by targeting inhibition of miR-181a and targeting HMGB1-induced autophagy
por: Wang, Lei, et al.
Publicado: (2021)

Downregulation of lncRNA ANRIL Inhibits Osteogenic Differentiation of Periodontal Ligament Cells via Sponging miR-7 through NF-κB Pathway
por: Liu, Xinwei, et al.
Publicado: (2021)

Upregulation of SOX2-activated lncRNA ANRIL promotes nasopharyngeal carcinoma cell growth
por: Wu, Jian-Hui, et al.
Publicado: (2018)

Diagnostic value of circulating lncRNA ANRIL and its correlation with coronary artery disease parameters
por: Hu, Yao, et al.
Publicado: (2019)

Effects of lncRNA ANRIL-knockdown on the proliferation, apoptosis and cell cycle of gastric cancer cells
por: Hu, Xueqian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4f5t9sap2q018kot3rrnrg96jo